ACLX Q2 2023 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M

Gross Profit

$14M95.1% margin

Operating Income

-$30M-206.7% margin

Net Income

-$24M-166.8% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

-20.2%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$30M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$624M

Total Liabilities

$330M

Stockholders' Equity

$294M

Cash & Equivalents

$304M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$0	—
Gross Profit	$14M	$0	—
Operating Income	-$30M	-$31M	+5.5%
Net Income	-$24M	-$31M	+22.5%